These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 6797259

  • 1. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. II. Sensitivity of gram-positive strains].
    Zembrzuska E.
    Acta Pol Pharm; 1981; 38(1):123-8. PubMed ID: 6797259
    [No Abstract] [Full Text] [Related]

  • 2. Susceptibility of bacteria isolated from non-parenteral preparations applied in paediatric hospitals to antibiotics.
    Zembrzuska-Sadkowska E, Parnowska W, Werakso B, Najer A.
    Acta Pol Pharm; 1995; 52(1):77-85. PubMed ID: 8960240
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK, Karginova E, Sahm D, Rothstein DM.
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [Abstract] [Full Text] [Related]

  • 8. [Identification and sensitivity of Streptococci to antibiotics].
    Monaci E.
    Quad Sclavo Diagn; 1983 Jun; 19(2):223-9. PubMed ID: 6427840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Characterization and antibacterial sensitivity of strains of Gram-positive cocci isolated from orally administered solid drugs].
    Garcia Arribas ML, de la Rosa Jorge MC, Mosso Romeo MA.
    J Pharm Belg; 1983 Jun; 38(3):140-6. PubMed ID: 6631654
    [No Abstract] [Full Text] [Related]

  • 11. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic susceptibility in oral bacteria.
    Dornbusch K.
    Swed Dent J; 1980 Mar 10; 4(1-2):9-15. PubMed ID: 6930116
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives.
    Wang G, Ella-Menye JR, Sharma V.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2177-81. PubMed ID: 16495055
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD, Jones DG, Sánchez Bruni SF.
    Chemotherapy; 2009 Apr 15; 55(4):270-7. PubMed ID: 19494489
    [Abstract] [Full Text] [Related]

  • 19. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V, Bruzzese T, Galli R, Simonetti N, Tronci N.
    Farmaco Sci; 1988 Apr 15; 43(7-8):619-25. PubMed ID: 3147199
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of coumermycin in comparison to other non-beta-lactam antibiotics against staphylococci, streptococci, and Clostridium difficile.
    Mittermayer H.
    Chemioterapia; 1987 Jun 15; 6(2 Suppl):163-4. PubMed ID: 3509379
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.